11 Firmen mit Ergebnissen für "avenues"

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

132 Ergebnisse für "avenues" unter Somagenetix

New avenues for pastoral development in sub-Saharan Africa - Zurich...

... New avenues for pastoral development in sub-Saharan Africa Hagmann, T ; Ifejika Speranza, C (2010 ... ). New avenues for pastoral development in sub-Saharan Africa. European Journal of Development Research ... New avenues for pastoral development in sub-Saharan Africa - Zurich Open Repository and Archive ... New avenues for pastoral development in sub-Saharan Africa - Zurich Open Repository and Archive ... New avenues for pastoral development in sub-Saharan Africa - Zurich Open Repository and Archive ...

UZH - Institute for Regenerative Medicine • IREM - Rust et al: New ...

... shown in a mouse model. The study opens up new avenues for treatment. ... the University of Zurich have shown in a mouse model. The study opens up new avenues for treatment ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

67 Ergebnisse für "avenues" unter ETH Entrepreneurship

Densifying Switzerland: Debates and Research Avenues for an Analysi...

... Densifying Switzerland: Debates and Research Avenues for an Analysis of Spatial Planning Policy ... Densifying Switzerland: Debates and Research Avenues for an Analysis of Spatial Planning Policy ... https://www.nsl.ethz.ch/fr/densifying-switzerland-debates-and-research- avenues-for-a-spatial ... Densifying Switzerland: Debates and Research Avenues for an Analysis of Spatial Planning Policy ...

[Ind. Eng. Chem. Res.] Molecular Epitaxy on Two-Dimensional Materia...

... -- at the two-dimensional (2D) material interfaces, opens new avenues towards the integration of 2D ... -dimensional (2D) material interfaces, opens new avenues towards the integration of 2D materials with a large ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

73 Ergebnisse für "avenues" unter University of Zurich

UZH - Institut für Medizinische Virologie - Group Huber

... immunodeficiencies, HIV infection), which may open avenues for tailored diagnostics and improved treatment options ... immunocompromised settings (transplantation, primary immunodeficiencies, HIV infection), which may open avenues for ...

UZH - Institut für Medizinische Virologie - Group Huber

... immunodeficiencies, HIV infection), which may open avenues for tailored diagnostics and improved treatment options ... immunocompromised settings (transplantation, primary immunodeficiencies, HIV infection), which may open avenues for ...

Mehr Ergebnisse

Dualsystems Biotech AG

http://www.dualsystems.com  

8952 Schlieren, Grabenstrasse 11a

 +41 44 738 50 00
 info@dualsystems.com

Dualsystems Biotech is a provider of proteomics services for industry and academia.

Dualsystems Biotech AG

Grabenstrasse 11a

8952 Schlieren

24 Ergebnisse für "avenues" unter Dualsystems Biotech AG

University of Manitoba – Dualsystems Biotech AG

... interest in rat primary neurons, and this has created new and exciting avenues for our research." Sari S ... receptors for our protein of interest in rat primary neurons, and this has created new and exciting avenues ...

CaptiRec Services, Ligand-receptor capture technology LRC-TriCEPS

... , and this has created new and exciting avenues for our research." Sari S. Hannila, PhD Associate Member ... interest in rat primary neurons, and this has created new and exciting avenues for our research." Sari S ... receptors for our protein of interest in rat primary neurons, and this has created new and exciting avenues ... our protein of interest in rat primary neurons, and this has created new and exciting avenues for our ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

8 Ergebnisse für "avenues" unter University Hospital Zurich​, Research and Education Office

Protein conformation- focus on skin in SSc – University Hospital Zurich

... other side, this project opens new avenues in the understanding the progression of dermal or visceral ... avenues in the understanding the progression of dermal or visceral organ fibrogenesis in SSc ...

Protein conformation- focus on skin in SSc – University Hospital Zurich

... other side, this project opens new avenues in the understanding the progression of dermal or visceral ... avenues in the understanding the progression of dermal or visceral organ fibrogenesis in SSc ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

9 Ergebnisse für "avenues" unter Roche Glycart AG

Pushing beyond what’s possible

... . Believing that they’d tried all avenues, Hasane and his team were disappointed. Then one day they had the ... . Believing that they’d tried all avenues, Hasane and his team were disappointed. Then one day they had the ...

Pushing beyond what’s possible

... . Believing that they’d tried all avenues, Hasane and his team were disappointed. Then one day they had the ... . Believing that they’d tried all avenues, Hasane and his team were disappointed. Then one day they had the ...

Mehr Ergebnisse

Molecular Partners AG

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

Molecular Partners AG

Wagistrasse 14

8952 Schlieren

1 Ergebnisse für "avenues" unter Molecular Partners AG

... ® leadership that has opened new avenues for delivering therapeutics that can achieve clinical outcomes other ... ® leadership that has opened new avenues for delivering therapeutics that can achieve clinical outcomes other ...

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

1 Ergebnisse für "avenues" unter Kuros Biosciences AG

... a drug rather than device opens additional avenues for pricing and reimbursement • Phase 2 clinical ... a drug rather than device opens additional avenues for pricing and reimbursement • Phase 2 clinical ...

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

3 Ergebnisse für "avenues" unter Blutspende SRK Zürich

... the theory of planned behavior: a review and avenues for further research. J Appl Soc Psychol 1998;28 ... the theory of planned behavior: a review and avenues for further research. J Appl Soc Psychol 1998;28 ...

Targeted exome sequencing defines novel and rare variants in comple...

... –293 284 TRANSFUSION Volume 58, February 2018 further avenues of investigation are required. For some ... –293 284 TRANSFUSION Volume 58, February 2018 further avenues of investigation are required. For some ...

Mehr Ergebnisse

CDR-Life AG

http://cdr-life.com/  

8810 Horgen, Tödistrasse 46


 info@cdr-life.com

CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.

CDR-Life AG

Tödistrasse 46

8810 Horgen

1 Ergebnisse für "avenues" unter CDR-Life AG

News - CDR-Life

... escape or resistance mechanisms Uncovering the long-term effects and exploring future avenues for ... escape or resistance mechanisms Uncovering the long-term effects and exploring future avenues for ...

Mehr Firmen

Nach oben